Science
Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
Headline as filed by Nature News.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| Nature News | Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer |
Nature, Published online: 17 September 2026; doi:10.1038/s41586-026-11134-xAuthor Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer |
0m | nature.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.